Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis

Blood

Volumn 92, Issue 4, 1998, Pages 1142-1149

  Sui, Xingwei ^b   Krantz, Sanford B ^a   You, Min ^b   Zhao, Zhizhuang ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENZYME INHIBITOR; ERYTHROPOIETIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL KINASE; RECOMBINANT ERYTHROPOIETIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; STEM CELL FACTOR; WORTMANNIN;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0032529283     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1142.416k42_1142_1149     Document Type: Article

References (45)

1. Krantz SB: Erythropoietin. Blood 77:419, 1991
2. Metcalf D: Hematopoietic regulators: Redundancy or subtlety? Blood 82:3515, 1993
3. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
4. Chui DH, Liao SK, Walker K: Fetal erythropoiesis in steel mutant mice. III. Defect in differentiation from BFU-E to CFU-E during early development. Blood 51:539, 1978
5. Russell ES: Hereditary anemias of the mouse: A review for genetics. Adv Genet 20:357, 1979
6. Nocka K, Majimber S, Chabot B, Ray P, Cervone M, Bernstein A, Besmer P: Expression of c-kit gene products in cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3:816, 1989
7. Wu H, Liu X, Jaenisch R, Lodish HF: Generation of committed erythoid BFU-E progenitors does not require erythropoietin and the erythropoietin receptor. Cell 83:59, 1995
8. McNiece IK, Langleley KE, Zsebo KM: Recombinant human stem cell factor synergies with GM-CSF, G-CSF, IL-3 and EPO to stimulate human progenitor cells of the myeloid and erythroid lineages. ExpHematol 19:226, 1991
9. Muta K, Krantz SB, Bondurant MC, Wickrema A: Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest 94:34, 1994
10. + cells. J Exp Med 183:837, 1996
11. Wu H, Klingmller U, Besmer P, Lodish HF: Interactions of the erythropoietin and stem-cell-factor receptors. Nature 377:242, 1995
12. Seger R, Seger D, Reszka AA, Munar ES, Eldar-Finkelman H, Dobrowolska G, Jensen AM, Campbell JS, Fischer EH, Krebs EG: Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII. J Biol Chem 269:25699, 1994
13. Sawada K, Krantz SB, Kans JS, Dessypris EN, Sawyer S, Glick AD, Civin CI: Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest 80:357, 1987
14. You M, Zhao Z: Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferongamma-stimulated activation of STAT transcription factors in HeLa cells. J Biol Chem 272:23376, 1997
15. Sui X, Krantz SB, Zhao Z: Identification of increased protein phosphatase activity in polycythemia vera erythroid progenitor cells. Blood 90:651, 1997
16. Sawada K, Krantz SB, Sawyer ST, Civin CI: Quantitation of specific binding of erythropoietin in Friend virus-infected erythroid cells. J Cell Physiol 137:337, 1988
17. Dai CH, Krantz SB, Koury ST, Kolla K: Polycythemia vera. IV. Specific binding of stem cell factor to normal and polycythemia vera highly purified erythroid progenitor cells. Br J Haematol 88:497, 1994
18. Jacobs-Helber SM, Penta K, Sun Z, Lawson A, Sawyer ST: Distinct signaling from stem cell factor and erythropoietin in HCD 57 cells. J Biol Chem 272:6850, 1997
19. Nishida E, Gotoh Y: The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18:128, 1993
20. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553, 1993
21. Blumer KJ, Johnson GL: Diversity in function and regulation of MAP kinase pathways. Trends Biochem Sci 19:236, 1994
22. Winston LA, Hunter T: Intracellular signalling: Putting JAKs on the kinase MAP. Curr Biol 6:668, 1996
23. Darnell JE Jr: STATs and gene regulation. Science 277:1630, 1997
24. Ihle JN: STATs: Signal transducers and activators of transcription. Cell 84:331, 1996
25. Penta K, Sawyer ST: Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells. J Biol Chem 270:31282, 1995
26. Pallard C, Gouilleux F, Charon M, Groner B, Gisselbrecht S, Dusanter-Fourt I: Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells. J Biol Chem 270:15942, 1995
27. Klingmuller U, Bergelson S, Hsiao JG, Lodish HF: Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5. Proc Natl Acad Sci USA 93:8324, 1996
28. Gotoh A, Takahira H, Mantel C, Litz-Jackson S, Boswell HS, Broxmeyer HE: Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines. Blood 88:138, 1996
29. Ryan JJ, Huang H, McReynolds LJ, Shelburne C, Hu-Li J, Huff TF, Paul WE: Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells. Exp Hematol 25:357, 1997
30. Sadowski HB, Shuai K, Darnell JE Jr, Gilman MZ: A common nuclear signal transduction pathway activated by growth factor. Science 261:1739, 1993
31. Udy CB, Towers RP, Snell RG, Wilkins RJ, Park S-H, Ram PA, Waxman DJ, Davey HW: Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94:7239, 1997
32. Liu X, Robinson GW, Wagner K-U, Garrett L, Wynshaw-Boris A, Hennighausen L: Stat5 is mandatory for adult mamfilary glauft development and lactogenesis. Gene Dev 11:179, 1997
33. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326, 1995
34. Marshall CJ: Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179, 1995
35. Koury MJ, Bondurant MC: Erythropoietin retards DNA break-down and prevents programmed death in erythroid progenitor cells. Science 248:378, 1990
36. Knoepp SM, Wiseh art-John son AE, Buse MG, Bradshaw CD, Ella KM, Meier KE: Synergistic effects of insulin and phorbol ester on mitogen-activated protein kinase in Rat-1 HIR cells. J Biol Chem 271:1678, 1996
37. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM: Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors. J Cell Biol 135:1633, 1996
38. Aronica SM, Gingras AC, Sonenberg N, Cooper S, Hague N, Broxmeyer HE: Macrophage inflammatory protein-1 alpha and interferon-inducible protein 10 inhibit synergistically induced growth factor stimulation of MAP kinase activity and suppress phosphorylation of eukaryotic initiation factor 4E and 4E binding protein 1. Blood 89:3582, 1997
39. O'Farrell AM, Ichihara M, Mui AL, Miyajima A: Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferate response. Blood 87:3655, 1996
40. Lev S, Blechman JM, Givol D, Yarden Y: Steel factor and c-kit protooncogene: Genetic lesssons in signal transduction. Crit Rev Oncog 5:141, 1994
41. Miura Y, Miura O, Ihle JN, Aoki N: Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem 269:29962, 1994
42. Damen JE, Liu L, Cutler RL, Krystal G: Erythropoietin stimulates the tyrosine phosphorylation of She and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood 82:2296, 1993
43. Verdier F, Chrétien S, Billat C, Gisselbrecht S, Lacombe C, Mayeux P: Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietminduced phosphatidylinositol 3-kinase activation. J Biol Chem 272. 26173, 1997
44. Klingmuller U, Wu H, Hsiao JG, Toker A, Duckworth BC, Cantley LC, Lodish HF: Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci USA 94:3016, 1997
45. Barber DL, Corless CN, Xia K, Roberts TM, D'Andrea AD: Erythropoietin activates Raf1 by an Shc-independent pathway in CTLL-EPO-R cells. Blood 89:55, 1997